The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

(2020) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool

(2020) L.P. Priesterbach‐Ackley et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

(2020) David N. Louis et al.   BRAIN PATHOLOGY

Genomics Paves the Way for Better Infant Medulloblastoma Therapy

(2020) Giles W. Robinson et al.   JOURNAL OF CLINICAL ONCOLOGY

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

(2020) Martin Mynarek et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study

(2020) Guillaume Gauchotte et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

A polyphenotypic malignant paediatric brain tumour presenting a MN1‐PATZ1 fusion, no epigenetic similarities with CNS High‐Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET‐MN1) and related to PATZ1 ‐fused sarcomas

(2020) Fanny Burel‐Vandenbos et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

(2020) Matthew Clarke et al.   Cancer Discovery

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

(2020) Philipp Sievers et al.   ACTA NEUROPATHOLOGICA

Guidelines for human gene nomenclature

(2020) Elspeth A. Bruford et al.   NATURE GENETICS

Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre

(2019) Zane Jaunmuktane et al.   Acta Neuropathologica Communications

Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors

(2019) Yukihiko Sonoda et al.   Brain Tumor Pathology

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation

(2019) David W. Ellison et al.   ACTA NEUROPATHOLOGICA

Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma

(2019) Julieann C. Lee et al.   ACTA NEUROPATHOLOGICA

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

(2019) Tanvi Sharma et al.   ACTA NEUROPATHOLOGICA

Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions

(2019) Damian Stichel et al.   ACTA NEUROPATHOLOGICA

Data Sets for the Reporting of Tumors of the Central Nervous System

(2019) David N. Louis et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

(2019) Farshad Nassiri et al.   NEURO-ONCOLOGY

Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

(2019) Elke Pfaff et al.   ACTA NEUROPATHOLOGICA

Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults

(2019) Christian Thomas et al.   ACTA NEUROPATHOLOGICA

Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

(2019) C Mircea S Tesileanu et al.   NEURO-ONCOLOGY

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

(2019) Ana S. Guerreiro Stucklin et al.   Nature Communications

Craniopharyngioma

(2019) Hermann L. Müller et al.   Nature Reviews Disease Primers

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

(2019) Bryan K. Li et al.   ACTA NEUROPATHOLOGICA

Medulloblastoma genomics in the modern molecular era

(2019) Rahul Kumar et al.   BRAIN PATHOLOGY

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

(2018) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

(2018) David Capper et al.   ACTA NEUROPATHOLOGICA

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)

(2018) David N. Louis et al.   ACTA NEUROPATHOLOGICA

EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity

(2018) Aurore Siegfried et al.   BRAIN PATHOLOGY

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

(2018) Giles W Robinson et al.   LANCET ONCOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing

(2018) Takahiro Ono et al.   SEMINARS IN NEUROLOGY

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

(2018) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

(2018) Guido Rindi et al.   MODERN PATHOLOGY

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

(2017) Edward C Schwalbe et al.   LANCET ONCOLOGY

Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification

(2016) David N. Louis et al.   BRAIN PATHOLOGY

A Global View on the Availability of Methods and Information in the Neuropathological Diagnostics of CNS Tumors: Results of an International Survey Among Neuropathological Units

(2016) Felipe Andreiuolo et al.   BRAIN PATHOLOGY

HGVS Recommendations for the Description of Sequence Variants: 2016 Update

(2016) Johan T. den Dunnen et al.   HUMAN MUTATION

Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles

(2016) Annett Hölsken et al.   Acta Neuropathologica Communications

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

(2015) Kristian W. Pajtler et al.   CANCER CELL

Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature

(2015) Rachael A. Vaubel et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

(2014) David N. Louis et al.   BRAIN PATHOLOGY

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients

(2014) Elizabeth Vera-Bolanos et al.   NEURO-ONCOLOGY

Spindle Cell Oncocytomas and Granular Cell Tumors of the Pituitary Are Variants of Pituicytoma

(2013) Ozgur Mete et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Histological variants of medulloblastoma are the most powerful clinical prognostic indicators

(2012) Maura Massimino et al.   PEDIATRIC BLOOD & CANCER

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

(2011) David W. Ellison et al.   ACTA NEUROPATHOLOGICA

Molecular subgroups of medulloblastoma: the current consensus

(2011) Michael D. Taylor et al.   ACTA NEUROPATHOLOGICA